Several months into the COVID-19 pandemic, this article takes a look back at how the launches of new oncology therapies have been impacted.
Matt Furlow
Advertisement
Articles by Matt Furlow
Advertisement
Latest Updated Articles
- How COVID-19 Has Affected Launches of New Oncology Therapies in the U.S.
Published: August 4th 2020 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
George Tidmarsh Out at FDA
2
Overcoming the Challenges of AI Adoption
3
Pharmaceutical Executive Daily: Pfizer Files Lawsuits Against Metsera and Novo Nordisk
4
Roundup: Biotech’s Most Recent Strategic Partnerships and Exclusive Licensing Agreements
5
